FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Oil prices rose as the IEA deployed an historic stock draw, yet Carlyle Group’s Currie argued there’s policy response...
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
Deficits are mounting as the Treasury plots heavy borrowing for the current and next fiscal years. Officials project ...
A former battery designer explains how America can reclaim global leadership by building next-gen materials on domest...
In a hypothetical SpaceX IPO in 2026, Meta’s Mark Zuckerberg could emerge as the biggest winner, driven by AI investm...
ECB board member Isabel Schnabel presses for a digital euro to counter stablecoin risks, signaling tighter regulation...
Bitcoin gave up weekend gains as oil surged and geopolitical tensions in the Middle East intensified, signaling renew...
In 2026, a rising rate environment and tighter underwriting are driving HELOC denials. This report explains how to re...
Ethereum faces a critical test as it nears the $2,000 mark. With cautious sentiment and uneven institutional interest...
A board director at Veracyte sold shares after a substantial stock run. This guide shows you how to interpret insider...
Samsung Electronics and several Korean firms pushed back on Open USD participation claims, saying they had no formal ...